These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24605049)

  • 21. Solid facial edema as a complication of acne vulgaris: treatment with isotretinoin.
    Friedman SJ; Fox BJ; Albert HL
    J Am Acad Dermatol; 1986 Aug; 15(2 Pt 1):286-9. PubMed ID: 2943761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isotretinoin in severe, recalcitrant cystic acne: a review.
    Rumsfield JA; West DP; Tse CS; Eaton ML; Robinson LA
    Drug Intell Clin Pharm; 1983 May; 17(5):329-33. PubMed ID: 6222891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical isotretinoin vs. topical retinoic acid in the treatment of acne vulgaris.
    Domínguez J; Hojyo MT; Celayo JL; Domínguez-Soto L; Teixeira F
    Int J Dermatol; 1998 Jan; 37(1):54-5. PubMed ID: 9522243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isotretinoin versus minocycline in cystic acne: a study of lipid metabolism.
    Pigatto PD; Finzi AF; Altomare GF; Polenghi MM; Vergani C; Vigotti G
    Dermatologica; 1986; 172(3):154-9. PubMed ID: 2938993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isotretinoin therapy for acne: a population-based study.
    Hogan DJ; Strand LM; Lane PR
    CMAJ; 1988 Jan; 138(1):47-50. PubMed ID: 2961430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arotinoid Ro 13-6298 and etretin: two new retinoids inferior to isotretinoin in sebum suppression and acne treatment.
    Harms M; Philippe I; Radeff B; Masouyé I; Geiger JM; Saurat JH
    Acta Derm Venereol; 1986; 66(2):149-54. PubMed ID: 2424239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isotretinoin-induced thrombocytopenia.
    Johnson TM; Rapini RP
    J Am Acad Dermatol; 1987 Nov; 17(5 Pt 1):838-9. PubMed ID: 2960702
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy of the fixed 1.2% clindamycin phosphate, 0.025% tretinoin gel formulation (Velac) and a proprietary 0.025% tretinoin gel formulation (Aberela) in the topical control of facial acne.
    Richter JR; Förström LR; Kiistala UO; Jung EG
    J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):227-33. PubMed ID: 9883434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrastructural changes in open comedones following treatment of cystic acne with isotretinoin.
    Zelickson AS; Strauss JS; Mottaz J
    Am J Dermatopathol; 1985 Jun; 7(3):241-4. PubMed ID: 2413783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A multicenter study of the effect of isotretinoin on nodular cystic acne].
    Papini M; Cavicchini S; Bellosta M; Colonna S
    G Ital Dermatol Venereol; 1986; 121(5):LXIII-LXVI. PubMed ID: 2947847
    [No Abstract]   [Full Text] [Related]  

  • 31. The relapses of cystic acne after isotretinoin treatment are age-related: a long-term follow-up study.
    Harms M; Masouyé I; Radeff B
    Dermatologica; 1986; 172(3):148-53. PubMed ID: 2938992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical vitamin-A-acid in acne.
    Zachariae H
    Acta Derm Venereol Suppl (Stockh); 1980; Suppl 89():65-70. PubMed ID: 6451128
    [No Abstract]   [Full Text] [Related]  

  • 33. [Oral isotretinoin therapy of acne conglobata].
    Török L; Kása M
    Orv Hetil; 1985 Apr; 126(17):1033-5. PubMed ID: 3157911
    [No Abstract]   [Full Text] [Related]  

  • 34. [Isotretinoin (Roaccutan). A new drug against severe acne].
    Austad J; Mørk NJ
    Tidsskr Nor Laegeforen; 1984 Aug; 104(24):1639-41. PubMed ID: 6236579
    [No Abstract]   [Full Text] [Related]  

  • 35. Isotretinoin versus placebo in the treatment of cystic acne. A randomized double-blind study.
    Peck GL; Olsen TG; Butkus D; Pandya M; Arnaud-Battandier J; Gross EG; Windhorst DB; Cheripko J
    J Am Acad Dermatol; 1982 Apr; 6(4 Pt 2 Suppl):735-45. PubMed ID: 6461677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris.
    Zaenglein AL; Shamban A; Webster G; Del Rosso J; Dover JS; Swinyer L; Stein L; Lin X; Draelos Z; Gold M; Thiboutot D
    J Drugs Dermatol; 2013 Jun; 12(6):619-25. PubMed ID: 23839176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isotretinoin and tetracycline in the management of severe nodulocystic acne.
    Lester RS; Schachter GD; Light MJ
    Int J Dermatol; 1985 May; 24(4):252-7. PubMed ID: 3159698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-dose isotretinoin in severe acne.
    Bellosta M; Vignini M; Miori L; Rabbiosi G
    Int J Tissue React; 1987; 9(5):443-6. PubMed ID: 2959631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-response relationship in isotretinoin therapy for conglobate acne.
    van der Meeren HL; van der Schroeff JG; Stijnen T; van Duren JA; van der Dries HA; van Voorst Vader PC
    Dermatologica; 1983; 167(6):299-303. PubMed ID: 6229429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of ovarian reserve and function in female patients treated with oral isotretinoin for severe acne: an exploratory study.
    Öztürk S; Öztürk T; Ucak H; Erden I; Demir B; Kayalı A; Cicek D
    Cutan Ocul Toxicol; 2015 Mar; 34(1):21-4. PubMed ID: 24678743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.